CBSCBS News·1hPolitics
score-0.65
FDA Launches Formal Safety Review of Mifepristone, Triggering Structured Regulatory Process for Medication Access Decisions
Original
FDA launches safety study for abortion pill mifepristone, source says
“Framing emphasizes potential restriction and regulatory action with cautionary language suggesting policy threat rather than neutral safety assessment.”